R Al-Shahi1, J S Y Fang, S C Lewis, C P Warlow. 1. Department of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Rustam.Al-Shahi@ed.ac.uk
Abstract
OBJECTIVE: To conduct a population based study of brain arteriovenous malformation (AVM) prevalence. METHODS: Multiple, overlapping sources of case ascertainment were used to establish the point prevalence of brain AVMs in the adult population of the Lothian health board of Scotland. Patients were sought retrospectively from all local general (family) practitioners, neurologists, neurosurgeons, stroke physicians, the specialist AVM clinic at the regional neuroscience centre, and routine coding of hospital discharge data. Case notes, brain imaging, and pathology reports were reviewed to validate each patient's diagnosis and to ensure that each was alive, over the age of 16 years, and resident in the geographical area of the study on the prevalence date of 30 June 1998. RESULTS: Of 148 potentially eligible people, 93 adults met the inclusion criteria. There were 40 women and 53 men. Men were significantly younger than women on the prevalence date (median age 39 years v 51 years, p = 0.003). Of those included, 25 (27%) had radiological evidence of prior therapeutic obliteration of their brain AVM and 9 (10%) had coexisting aneurysms. The minimum crude brain AVM prevalence was 15 per 100 000 adults and capture-recapture analysis gave an ascertainment adjusted prevalence of 18 (95% confidence interval 16 to 24) per 100 000 adults. CONCLUSIONS: The minimum estimate of brain AVM prevalence helps to assess its burden and comparative epidemiology and stresses the importance of brain AVMs as a cause of long term disability in adults.
OBJECTIVE: To conduct a population based study of brain arteriovenous malformation (AVM) prevalence. METHODS: Multiple, overlapping sources of case ascertainment were used to establish the point prevalence of brain AVMs in the adult population of the Lothian health board of Scotland. Patients were sought retrospectively from all local general (family) practitioners, neurologists, neurosurgeons, stroke physicians, the specialist AVM clinic at the regional neuroscience centre, and routine coding of hospital discharge data. Case notes, brain imaging, and pathology reports were reviewed to validate each patient's diagnosis and to ensure that each was alive, over the age of 16 years, and resident in the geographical area of the study on the prevalence date of 30 June 1998. RESULTS: Of 148 potentially eligible people, 93 adults met the inclusion criteria. There were 40 women and 53 men. Men were significantly younger than women on the prevalence date (median age 39 years v 51 years, p = 0.003). Of those included, 25 (27%) had radiological evidence of prior therapeutic obliteration of their brain AVM and 9 (10%) had coexisting aneurysms. The minimum crude brain AVM prevalence was 15 per 100 000 adults and capture-recapture analysis gave an ascertainment adjusted prevalence of 18 (95% confidence interval 16 to 24) per 100 000 adults. CONCLUSIONS: The minimum estimate of brain AVM prevalence helps to assess its burden and comparative epidemiology and stresses the importance of brain AVMs as a cause of long term disability in adults.
Authors: Christian Stapf; Daniel L Labovitz; Robert R Sciacca; Henning Mast; Jay P Mohr; Ralph L Sacco Journal: Cerebrovasc Dis Date: 2002 Impact factor: 2.762
Authors: Natan Shtraus; Dan Schifter; Benjamin W Corn; Shimon Maimon; Shlomi Alani; Vladimir Frolov; Diana Matceyevsky; Andrew A Kanner Journal: J Neurooncol Date: 2010-04-10 Impact factor: 4.130
Authors: J van Beijnum; H B van der Worp; H M Schippers; O van Nieuwenhuizen; L J Kappelle; G J E Rinkel; J W Berkelbach van der Sprenkel; C J M Klijn Journal: J Neurol Neurosurg Psychiatry Date: 2007-01-26 Impact factor: 10.154
Authors: Dennis R Buis; René van den Berg; Geert Lycklama; H Bart van der Worp; Clemens M F Dirven; W Peter Vandertop Journal: J Neurol Date: 2004-11 Impact factor: 4.849
Authors: Aditya Bharatha; Marie E Faughnan; Helen Kim; Tony Pourmohamad; Timo Krings; Pinar Bayrak-Toydemir; Ludmila Pawlikowska; Charles E McCulloch; Michael T Lawton; Christopher F Dowd; William L Young; Karel G Terbrugge Journal: Stroke Date: 2011-10-27 Impact factor: 7.914
Authors: Sergey I Nikolaev; Sandra Vetiska; Ximena Bonilla; Emilie Boudreau; Suvi Jauhiainen; Behnam Rezai Jahromi; Nadiya Khyzha; Peter V DiStefano; Santeri Suutarinen; Tim-Rasmus Kiehl; Vitor Mendes Pereira; Alexander M Herman; Timo Krings; Hugo Andrade-Barazarte; Takyee Tung; Taufik Valiante; Gelareh Zadeh; Mike Tymianski; Tuomas Rauramaa; Seppo Ylä-Herttuala; Joshua D Wythe; Stylianos E Antonarakis; Juhana Frösen; Jason E Fish; Ivan Radovanovic Journal: N Engl J Med Date: 2018-01-03 Impact factor: 91.245